A nanovesicle platform to deliver neoantigens and immune checkpoint inhibitors: To ASPIRE for novel cancer vaccines

Bibliographic Details
Main Authors: Hongwei Cheng, Hwan‐Ching Tai
Format: Article
Language:English
Published: Wiley 2022-06-01
Series:MedComm – Biomaterials and Applications
Online Access:https://doi.org/10.1002/mba2.4
_version_ 1811166438438731776
author Hongwei Cheng
Hwan‐Ching Tai
author_facet Hongwei Cheng
Hwan‐Ching Tai
author_sort Hongwei Cheng
collection DOAJ
first_indexed 2024-04-10T15:52:22Z
format Article
id doaj.art-02c83e6b19354c718ffe9f05db85a99f
institution Directory Open Access Journal
issn 2769-643X
language English
last_indexed 2024-04-10T15:52:22Z
publishDate 2022-06-01
publisher Wiley
record_format Article
series MedComm – Biomaterials and Applications
spelling doaj.art-02c83e6b19354c718ffe9f05db85a99f2023-02-10T23:20:13ZengWileyMedComm – Biomaterials and Applications2769-643X2022-06-0111n/an/a10.1002/mba2.4A nanovesicle platform to deliver neoantigens and immune checkpoint inhibitors: To ASPIRE for novel cancer vaccinesHongwei Cheng0Hwan‐Ching Tai1State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, Center for Molecular Imaging and Translational Medicine School of Public Health, Xiamen University Xiamen P. R. ChinaDepartment of Laboratory Medicine, State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics School of Public Health, Xiamen University Xiamen P. R. Chinahttps://doi.org/10.1002/mba2.4
spellingShingle Hongwei Cheng
Hwan‐Ching Tai
A nanovesicle platform to deliver neoantigens and immune checkpoint inhibitors: To ASPIRE for novel cancer vaccines
MedComm – Biomaterials and Applications
title A nanovesicle platform to deliver neoantigens and immune checkpoint inhibitors: To ASPIRE for novel cancer vaccines
title_full A nanovesicle platform to deliver neoantigens and immune checkpoint inhibitors: To ASPIRE for novel cancer vaccines
title_fullStr A nanovesicle platform to deliver neoantigens and immune checkpoint inhibitors: To ASPIRE for novel cancer vaccines
title_full_unstemmed A nanovesicle platform to deliver neoantigens and immune checkpoint inhibitors: To ASPIRE for novel cancer vaccines
title_short A nanovesicle platform to deliver neoantigens and immune checkpoint inhibitors: To ASPIRE for novel cancer vaccines
title_sort nanovesicle platform to deliver neoantigens and immune checkpoint inhibitors to aspire for novel cancer vaccines
url https://doi.org/10.1002/mba2.4
work_keys_str_mv AT hongweicheng ananovesicleplatformtodeliverneoantigensandimmunecheckpointinhibitorstoaspirefornovelcancervaccines
AT hwanchingtai ananovesicleplatformtodeliverneoantigensandimmunecheckpointinhibitorstoaspirefornovelcancervaccines
AT hongweicheng nanovesicleplatformtodeliverneoantigensandimmunecheckpointinhibitorstoaspirefornovelcancervaccines
AT hwanchingtai nanovesicleplatformtodeliverneoantigensandimmunecheckpointinhibitorstoaspirefornovelcancervaccines